Côte d'ivoire Country Commercial Guide
Learn about the market conditions, opportunities, regulations, and business conditions in côte d'ivoire, prepared by at U.S. Embassies worldwide by Commerce Department, State Department and other U.S. agencies’ professionals
Select Country Guide
Côte d’Ivoire - Healthcare and Medical Devices
Last published date:

Overview

Côte d’Ivoire’s healthcare sector is undergoing modernization to improve access, quality, and efficiency. The government, in collaboration with donor partners and private investors, is investing in hospital infrastructure, health workforce development, and digital health solutions. Despite these efforts, the healthcare system faces challenges including uneven access between urban and rural areas, limited diagnostic and laboratory capabilities, and a reliance on imported pharmaceuticals and medical devices.

The country’s health expenditure in 2023 was estimated at approximately 5.7% of GDP, reflecting moderate investment in public health, while out-of-pocket spending remains high. Urban centers such as Abidjan and Bouaké host the majority of tertiary hospitals, specialized clinics, and private facilities, while rural populations often rely on primary health centers with limited resources.

Côte d’Ivoire’s infrastructure reflects a growing need for modern health facilities equipped with advanced medical technologies. U.S. companies specializing in hospital construction, medical equipment, and health technology solutions have strong commercial opportunities to support the country’s efforts to expand and upgrade its healthcare infrastructure, including advancing digital health and cybersecurity through telemedicine, health IT, and secure data systems; strengthening supply chain and logistics with cold-chain, last-mile delivery, and inventory solutions; supporting construction and equipment supply in new hospitals and labs via PPPs; addressing workforce shortages through training and capacity building in medical education and biomedical engineering; and enabling health financing and insurance with digital payments, claims management, and insurance technology solutions.

Côte d’Ivoire’s medical device and pharmaceutical markets are largely import-dependent, with European and Asian suppliers dominating the market. U.S. companies have opportunities in high-value medical devices, hospital infrastructure, digital health, laboratory diagnostics, and supply chain management. Critical areas for investment and partnership include maternal and child health, infectious disease management, and chronic disease care (e.g., diabetes and cardiovascular diseases).

The government has introduced regulatory frameworks to improve quality and safety, including the National Agency for Pharmaceutical Regulation and the National Health Development Plan (PNDS 2021–2025), which emphasizes universal health coverage, digital health, and private sector participation.

A December 2025 health cooperation agreement between the Government of the United States and Côte d’Ivoire further strengthens bilateral engagement in the sector, creating opportunities for U.S. companies to participate in healthcare infrastructure development, medical equipment supply, digital health solutions, and capacity-building initiatives supported through government-to-government collaboration

Leading Sub-sectors

Côte d’Ivoire’s healthcare market offers opportunities across multiple sub-sectors where U.S. companies can leverage technology, product expertise, and project management solutions. Key sub-sectors include:

  • Medical Devices and Diagnostic Equipment: Hospitals and laboratories are modernizing their equipment for imaging, patient monitoring, surgical procedures, and laboratory diagnostics. U.S. firms offering high-quality, innovative devices are highly competitive.
     
  • Hospital Infrastructure and Construction: Investment in new hospitals, renovation of existing facilities, and the development of specialized clinics create opportunities for engineering, construction, and project management services.
     
  • Pharmaceuticals and Biologics: The import-driven pharmaceutical market presents opportunities for U.S. suppliers of high-quality medicines, vaccines, and biologics, particularly for chronic and infectious diseases.
     
  • Digital Health Solutions: Telemedicine, electronic health records, mobile health applications, and hospital management software are increasingly adopted to improve care delivery and patient monitoring.
     
  • Laboratory Services and Clinical Diagnostics: Growing demand for modern laboratory infrastructure, diagnostic reagents, and testing equipment, including for infectious diseases and public health programs.
     
  • Medical Training and Capacity Building: U.S. institutions can provide technical training, skills development, and continuing medical education to strengthen the healthcare workforce and support the implementation of new technologies.

These sub-sectors align with Côte d’Ivoire’s National Health Development Plan, donor-funded programs, and public-private partnership initiatives, offering entry points for U.S. companies with innovative products, training expertise, and healthcare project experience.

Opportunities

Côte d’Ivoire presents multiple opportunities for U.S. companies in healthcare and medical devices:

  • Hospital Modernization Projects: Expansion and renovation of hospitals and clinics across the country, including public-private partnership initiatives, create demand for equipment, construction, and hospital management systems.
     
  • Laboratory Diagnostics and Testing: Investments in modern laboratories for infectious diseases, cancer screening, and routine diagnostics open opportunities for high-quality laboratory equipment, reagents, and technical training.
     
  • Digital Health and Telemedicine: Government initiatives encourage telehealth adoption to reach rural populations. Solutions for electronic medical records, patient monitoring, and remote diagnostics are in demand.
     
  • Maternal and Child Health Programs: Investments in specialized equipment and training for maternal and pediatric care, driven by public health priorities and donor-funded programs, offer opportunities for U.S. providers of medical devices and training services.
     
  • Pharmaceutical and Vaccine Supply: Import demand for high-quality pharmaceuticals and vaccines, particularly for chronic and infectious diseases, presents commercial opportunities for U.S. manufacturers and distributors.
     
  • Healthcare Workforce Development: U.S. companies and institutions can participate in skills development, continuing education, and technical support for clinicians, nurses, laboratory technicians, and biomedical engineers.
     
  • Public Health Initiatives: Donor-funded programs targeting malaria, HIV/AIDS, and other endemic diseases provide opportunities for U.S. firms in diagnostics, laboratory support, and preventive healthcare technologies.

Resources

  • Ministère de la Santé et de l’Hygiène Publique (MSHP)    
    Government ministry responsible for national health policy, hospital oversight, and public health programs. Coordinates with donors, manages public hospitals, and regulates healthcare standards. Key entry point for U.S. companies providing equipment, hospital services, and technical expertise.
     
  • Autorité Ivoirienne de Régulation Pharmaceutique (ANRP)    
    Regulates the import, distribution, and quality control of pharmaceuticals and medical devices. Ensures compliance with safety and quality standards, making it essential for U.S. suppliers.
     
  • Institut National de Santé Publique (INSP)    
    Public institution that provides healthcare services, clinical services in the medical and pharmaceutical fields, medical biology, traditional medicine, and clinical services related to research. Coordinates the activities of public health institutes, centers, and laboratories, provides epidemiological surveillance, manages and analyzes health data, and disseminates information. Develops research, training, health promotion, and the implementation of innovative models to strengthen prevention, response, and management of public health issues in Côte d’Ivoire.
     
  • Public Hospitals and University Hospital Centers (CHU Abidjan, CHU Bouaké)    
    Major public hospitals and referral centers for tertiary care. Require advanced medical equipment, diagnostics, and hospital management solutions. U.S. firms can engage through direct procurement or PPPs.
     
  • World Health Organization (WHO) Côte d’Ivoire
    Supports public health programs, disease surveillance, and technical assistance. Collaborates with government and private sector on public health initiatives. Opportunities exist for U.S. companies supplying diagnostics, vaccines, and health technology.
     
  • UNICEF Côte d’Ivoire
    Focused on child and maternal health, nutrition, and vaccination programs. Partners with government and suppliers to provide medical equipment and training.

×

Global Business Navigator Chatbot Beta

Welcome to the Global Business Navigator, an artificial intelligence (AI) Chatbot from the International Trade Administration (ITA). This tool, currently in beta version testing, is designed to provide general information on the exporting process and the resources available to assist new and experienced U.S. exporters. The Chatbot, developed using Microsoft’s Azure AI services, is trained on ITA’s export-related content and aims to quickly get users the information they need. The Chatbot is intended to make the benefits of exporting more accessible by understanding non-expert language, idiomatic expressions, and foreign languages.

Limitations

As a beta product, the Chatbot is currently being tested and its responses may occasionally produce inaccurate or incomplete information. The Chatbot is trained to decline out of scope or inappropriate requests. The Chatbot’s knowledge is limited to the public information on the Export Solutions web pages of Trade.gov, which covers a wide range of topics on exporting. While it cannot provide responses specific to a company’s product or a specific foreign market, its reference pages will guide you to other relevant government resources and market research. Always double-check the Chatbot’s responses using the provided references or by visiting the Export Solutions web pages on Trade.gov. Do not use its responses as legal or professional advice. Inaccurate advice from the Chatbot would not be a defense to violating any export rules or regulations.

Privacy

The Chatbot does not collect information about users and does not use the contents of users’ chat history to learn new information. All feedback is anonymous. Please do not enter personally identifiable information (PII), sensitive, or proprietary information into the Chatbot. Your conversations will not be connected to other interactions or accounts with ITA. Conversations with the Chatbot may be reviewed to help ITA improve the tool and address harmful, illegal, or otherwise inappropriate questions.

Translation

The Chatbot supports a wide range of languages. Because the Chatbot is trained in English and responses are translated, you should verify the translation. For example, the Chatbot may have difficulty with acronyms, abbreviations, and nuances in a language other than English.

Privacy Program | Information Quality Guidelines | Accessibility